Literature DB >> 11087745

Phospholipase Cdelta1 is a guanine nucleotide exchanging factor for transglutaminase II (Galpha h) and promotes alpha 1B-adrenoreceptor-mediated GTP binding and intracellular calcium release.

K J Baek1, S Kang, D Damron, M Im.   

Abstract

Effectors involved in G protein-coupled receptor signaling modulate activity of GTPases through GTPase-activating protein or guanine nucleotide exchanging factor (GEF). Phospholipase Cdelta1 (PLCdelta1) is an effector in tissue transglutaminase (TGII)-mediated alpha1B-adrenoreceptor (alpha(1B)AR) signaling. We investigated whether PLCdelta1 modulates TGII activity. PLCdelta1 stimulated GDP release from TGII in a concentration-dependent manner, resulting in an increase in GTPgammaS binding to TGII. PLCdelta1 also inhibited GTP hydrolysis by TGII that was independent from the alpha(1B)AR. These results indicate that PLCdelta1 is GEF for TGII and stabilizes the GTP.TGII complex. When GEF function of PLCdelta1 was compared with that of the alpha(1B)AR, the alpha(1B)AR-mediated GTPgammaS binding to TGII was greater than PLCdelta1-mediated binding and was accelerated in the presence of PLCdelta1. Thus, the alpha(1B)AR is the prime GEF for TGII, and GEF activity of PLCdelta1 promotes coupling efficacy of this signaling system. Overexpression of TGII and its mutants with and without PLCdelta1 resulted in an increase in alpha(1B)AR-stimulated Ca2+ release from intracellular stores in a TGII-specific manner. We conclude that PLCdelta1 assists the alpha(1B)AR function through its GEF action and is primarily activated by the coupling of TGII to the cognate receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087745     DOI: 10.1074/jbc.M008252200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Transglutaminase regulation of cell function.

Authors:  Richard L Eckert; Mari T Kaartinen; Maria Nurminskaya; Alexey M Belkin; Gozde Colak; Gail V W Johnson; Kapil Mehta
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 3.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

4.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine.

Authors:  Ju-Hong Jeon; Kyung-Ho Choi; Sung-Yup Cho; Chai-Wan Kim; Dong-Myung Shin; Joon-Cheol Kwon; Kye-Yong Song; Sang-Chul Park; In-Gyu Kim
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  Dual activation of phospholipase C-epsilon by Rho and Ras GTPases.

Authors:  Jason P Seifert; Yixing Zhou; Stephanie N Hicks; John Sondek; T Kendall Harden
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

6.  Transglutaminase 2 regulates the GTPase-activating activity of Bcr.

Authors:  Sun-Ju Yi; John Groffen; Nora Heisterkamp
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

7.  Inducible knockout mutagenesis reveals compensatory mechanisms elicited by constitutive BK channel deficiency in overactive murine bladder.

Authors:  Franz Sprossmann; Patrick Pankert; Ulrike Sausbier; Angela Wirth; Xiao-Bo Zhou; Johannes Madlung; Hong Zhao; Iancu Bucurenciu; Andreas Jakob; Tobias Lamkemeyer; Winfried Neuhuber; Stefan Offermanns; Michael J Shipston; Michael Korth; Alfred Nordheim; Peter Ruth; Matthias Sausbier
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

8.  Distribution of transglutaminase in pear pollen tubes in relation to cytoskeleton and membrane dynamics.

Authors:  Stefano Del Duca; Claudia Faleri; Rosa Anna Iorio; Mauro Cresti; Donatella Serafini-Fracassini; Giampiero Cai
Journal:  Plant Physiol       Date:  2013-02-08       Impact factor: 8.340

9.  Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

Authors:  Jee Young Hwang; Lingegowda S Mangala; Jansina Y Fok; Yvonne G Lin; William M Merritt; Whitney A Spannuth; Alpa M Nick; Derek J Fiterman; Pablo E Vivas-Mejia; Michael T Deavers; Robert L Coleman; Gabriel Lopez-Berestein; Kapil Mehta; Anil K Sood
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 10.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.